HHV8 ORF50 Polyclonal Antibody, PE-Cy5 Conjugated
Product Specifications
Background
HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
Synonyms
HHV8 ORF50; HHV 8; Human Herpes Virus 8; Human herpesvirus 8; Kaposi's sarcoma associated herpes virus; Kaposi's sarcoma associated herpesvirus; KSHV; replication and transcription activator; RTA
Gene ID
4961526
Swiss Prot
F5HCV3
Host
Rabbit
Cross Reactivity
Virus
Immunogen
601-691/691
Target
HHV8 ORF50
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from C-terminus of HHV8 ORF50 strain GK18
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
1µg/µl
Dilution
WB (1:500-1000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
4961526
Cross Reactivity Details
Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
